16.3 Agitated Saline Bubble Studies, Ultrasound Enhancing Agents & Shunt Timing

16.3 Agitated Saline Bubble Studies & Intracardiac vs Intrapulmonary Shunt Timing

Clinical Core: Agitated saline contrast echocardiography—commonly termed a "bubble study"—is a highly sensitive, bedside diagnostic technique for detecting cardiovascular right-to-left and bidirectional shunting. The modality exploits a fundamental physiological barrier: the human pulmonary capillary bed filters out microbubbles larger than its internal caliber ($7$ to $10\ \mu\text{m}$). Consequently, microbubbles injected into the peripheral venous system opacify only the right-sided cardiac chambers unless an intracardiac defect, intrapulmonary arteriovenous malformation (AVM), systemic venous anomaly, or postoperative baffle leak provides an abnormal conduit into the systemic circulation. In pediatric cardiology, rigorous adherence to transit timing (cardiac cycles), provocative hemodynamic maneuvers, and injection site selection (left arm vs. right arm) is mandatory to differentiate between Patent Foramen Ovale (PFO), Atrial Septal Defects (ASD), Persistent Left Superior Vena Cava (PLSVC), and intrapulmonary shunting in conditions such as Hepatopulmonary Syndrome and palliated single-ventricle circulations.

---

Physics & Preparation of Agitated Saline

Pulmonary Capillary Filtration Barrier Principle:

   Agitated Saline Injection:              Normal Pulmonary Circulation:
   ┌─────────────────────────────┐         ┌─────────────────────────────┐
   │ Microbubbles: >10 to 15 µm  │  ─────► │ Pulmonary Capillaries:      │  ─────► NO BUBBLES IN LA!
   │ (Room air + Saline + Blood) │         │ Internal Caliber: 7 - 10 µm │      (Filtered & Absorbed)
   └─────────────────────────────┘         └──────────────┬──────────────┘
                                                          │
   Pathologic Shunting Pathways:                          │
   • Intracardiac Shunt (PFO/ASD): 1 - 3 Cycles ◄─────────┤
   • Intrapulmonary Shunt (PAVMs): 4 - 6 Cycles ◄─────────┘

The Pulmonary Capillary Filter

The internal caliber of healthy human pulmonary capillaries measures between 7 and 10 micrometers ($\mu\text{m}$). Properly prepared agitated saline generates microbubbles containing room air ranging from $>10$ to over $15\ \mu\text{m}$ in diameter. Because these microbubbles are substantially larger than the pulmonary capillaries, they are completely trapped, broken down, and absorbed by pulmonary capillary endothelial diffusion during their first pass through the lungs. Under normal anatomical conditions, zero microbubbles reach the left atrium, left ventricle, or systemic arterial circulation.

Standardized Solution Preparation Protocol

To achieve dense, reproducible acoustic opacification without injecting macro-emboli, clinical protocols mandate strict preparation:

1. Hardware Configuration: Two 10-mL sterile Luer-lock syringes connected to a heavy-duty three-way stopcock.
2. Component Formulation:
   • 9.0 mL of sterile, bacteriostatic-free normal saline ($0.9%\ \text{NaCl}$).
   • 0.5 to 1.0 mL of sterile room air.
   • 0.5 mL of aspirated autologous blood drawn from the patient's intravenous line.
3. The Physiological Role of Blood: Adding a small aliquot of blood is critical. Blood proteins (albumin, globulins) significantly lower the surface tension of the fluid mixture. This stabilizes the microbubble gas-liquid interface, producing dramatically smaller, more uniform microbubbles ($10-15\ \mu\text{m}$), quadrupling bubble concentration, and prolonging intravascular acoustic persistence compared to saline and air alone.
4. Agitation Technique: The stopcock is opened, and the fluid-air mixture is forcefully exchanged back and forth between the two syringes for at least 10 to 15 rapid, vigorous passes until an opaque, milky-white emulsion is formed. It is immediately injected as a brisk bolus into the peripheral IV line.

---

Injection Protocol & Provocative Hemodynamics

Hemodynamic Mechanics of the Valsalva Maneuver:

1. Resting Hemodynamics (PFO Closed):       2. Strain Phase (Pressure Equalizes):    3. Release Phase (PFO Flap Pops Open!):
   ┌────────────────────────────────┐         ┌────────────────────────────────┐       ┌────────────────────────────────┐
   │  RA: 3-5 mmHg  │  LA: 6-10 mmHg│         │ Intrathoracic pressure rises;  │       │ Massive venous return surge    │
   │      PFO Flap Sealed!          │  ─────► │ systemic venous return halts;  │ ─────► │ RA pressure abruptly shoots to │
   │  (LA pressure holds septum     │         │ RA opacifies densely with      │       │ 15-20 mmHg (RA > LA!)          │
   │   primum against secundum)     │         │ microbubbles under high strain │       │ PFO flap pushed open: BUBBLES  │
   └────────────────────────────────┘         └────────────────────────────────┘       │ FLOOD INTO LEFT ATRIUM!        │
                                                                                       └────────────────────────────────┘

The Resting Interatrial Pressure Gradient

In a healthy resting individual, Left Atrial (LA) mean pressure ($6-10\ \text{mmHg}$) exceeds Right Atrial (RA) mean pressure ($3-5\ \text{mmHg}$). The Patent Foramen Ovale (PFO) is a flap valve composed of the mobile septum primum resting against the rigid muscular septum secundum on the left atrial side. Because LA pressure is higher, the septum primum is held firmly closed against the septum secundum, preventing left-to-right or right-to-left flow. Consequently, an agitated saline injection administered at rest will frequently yield a false-negative result even in the presence of a widely patent PFO.

Provocative Maneuvers

To detect latent or intermittent right-to-left shunting, the sonographer must transiently reverse the interatrial pressure gradient, driving RA pressure above LA pressure:

1. The Standard Valsalva Maneuver (Cooperative Children/Adolescents):
   • Phase 1 (Strain Phase): The patient takes a normal breath and forcefully strains against a closed glottis (or blows against an occluded syringe) for 10 seconds. Intrathoracic pressure rises, collapsing the systemic veins and impeding venous return to the heart.
   • Phase 2 (Injection Timing): Agitated saline is injected into the peripheral line 5 seconds into the strain phase, filling the vena cava and right atrium with microbubbles.
   • Phase 3 (Release Phase - The Critical Diagnostic Frame!): The patient abruptly releases the strain and takes a deep breath. A massive bolus of pooled systemic venous blood immediately surges from the inferior and superior vena cava into the right atrium. Right atrial pressure abruptly spikes ($15-20\ \text{mmHg}$), significantly exceeding left atrial pressure. The septum primum is pushed open toward the left atrium, and a dense cloud of microbubbles traverses the PFO.
2. Provocation in Infants and Young Children: Infants cannot perform a voluntary Valsalva maneuver. In this population, equivalent hemodynamic pressure reversals are triggered by:
   • Crying or Vigorous Coughing: Crying against a closed glottis functions physiologically as an infant Valsalva. Injecting agitated saline during quiet state and observing the interatrial septum during the subsequent crying surge reveals the shunt.
   • Transient Abdominal Compression: Gentle, transient manual compression of the upper abdomen compresses the hepatic veins and inferior vena cava, increasing systemic venous return and raising RA pressure upon rapid release.

Intravenous Access Site: Left Arm vs. Right Arm

• Standard Upper Extremity Access: Right arm or left arm antecubital/forearm veins are standard for routine shunt detection.
• Mandatory Left Arm Injection for Persistent Left SVC: If a dilated coronary sinus is visualized on 2D imaging, the agitated saline MUST be injected into the LEFT arm. As detailed below, left-arm injection is the gold standard diagnostic test for Persistent Left Superior Vena Cava (PLSVC).

---

Diagnostic Interpretation & Timing Patterns

Diagnostic Timing & Shunt Localization Decision Tree:

Agitated Saline Bolus Opacifies Right Atrium (Frame 0)
   │
   ├──► Microbubbles appear in Left Heart within 1 to 3 Cardiac Cycles?
   │     │
   │     ├──► YES ──► INTRACARDIAC SHUNT (PFO, ASD, Unroofed Coronary Sinus)
   │
   ├──► Microbubbles appear in Left Heart after 4 to 6 Cardiac Cycles (Delayed)?
   │     │
   │     ├──► YES ──► INTRAPULMONARY SHUNT (Hepatopulmonary Syndrome, PAVMs)
   │                  (Bubbles enter LA from Pulmonary Veins, NOT interatrial septum!)
   │
   └──► Injected into LEFT ARM: Does Coronary Sinus opacify BEFORE the Right Atrium?
         │
         ├──► YES ──► PERSISTENT LEFT SUPERIOR VENA CAVA (PLSVC)

1. Intracardiac Shunts (PFO, ASD, VSD)

• Diagnostic Timing: Microbubbles appear in the left atrium (and subsequently the left ventricle) within 1 to 3 cardiac cycles following complete opacification of the right atrium.
• Direct Visualization: In the apical 4-chamber or subcostal view, microbubbles can often be directly visualized crossing the fossa ovalis or defect margin.
• Semi-Quantitative Grading of Intracardiac Shunt Size:
  • Grade 1 (Mild): $1$ to $9$ microbubbles observed in the left atrium on a single video frame.
  • Grade 2 (Moderate): $10$ to $30$ microbubbles observed in the left atrium.
  • Grade 3 (Severe / Dense): $>30$ microbubbles, or dense, opacifying clouding of the left atrium and ventricle with acoustic shadowing.
• Spontaneous vs. Provoked: Reporting must differentiate between shunting that occurs spontaneously during resting tidal breathing versus shunting provoked strictly during the release phase of a Valsalva maneuver or crying.

2. Intrapulmonary Shunts (Hepatopulmonary Syndrome & Fontan PAVMs)

• Diagnostic Timing: Microbubbles appear in the left atrium after 4 to 6 cardiac cycles (delayed transit, typically 4 to 8 cycles) following right atrial opacification.
• Anatomical Route: Microbubbles do not cross the interatrial septum. Instead, high-resolution imaging demonstrates microbubbles emerging directly from the individual pulmonary venous orifices into the left atrial cavity.
• Clinical Settings:
  1. Hepatopulmonary Syndrome (HPS): Occurs in pediatric end-stage liver disease, biliary atresia, or severe cirrhosis. Endogenous vasodilators (such as nitric oxide and endothelin-B mediated pathways) escape hepatic clearance, causing massive pre-capillary and capillary pulmonary vascular dilation ($15$ to $100\ \mu\text{m}$). These dilated channels allow agitated saline microbubbles to pass through the lung parenchyma unhindered, producing chronic arterial hypoxemia and cyanosis.
  2. Pulmonary Arteriovenous Malformations (PAVMs) post-Glenn or post-Fontan: In children with single-ventricle palliation who have undergone a bidirectional Glenn shunt (superior vena cava anastomosed to the pulmonary artery), hepatic venous blood is diverted away from the pulmonary circulation. The absence of a critical, unidentified hepatic humoral factor ("hepatic factor") leads to the progressive formation of diffuse microscopic PAVMs in the lungs, causing late, progressive cyanosis. Agitated saline injected into the upper extremity demonstrates delayed transit into the single atrium via the pulmonary veins.
  3. Hereditary Hemorrhagic Telangiectasia (HHT / Osler-Weber-Rendu): Congenital macroscopic pulmonary arteriovenous fistulas.

3. Persistent Left Superior Vena Cava (PLSVC)

Persistent Left SVC is the most common systemic venous anomaly, present in approximately $0.3%$ to $0.5%$ of the general population and up to $3%$ to $5%$ of children with congenital heart disease.

• Pathophysiology: Failure of regression of the left anterior cardinal vein. A left-sided SVC courses anterior to the aortic arch, passes lateral to the left atrium, and drains directly into the coronary sinus, causing marked dilation of the coronary sinus.
• The Agitated Saline Test Protocol:
  • Left Arm Injection: Microbubbles travel down the left SVC and opacify the dilated Coronary Sinus FIRST before entering the Right Atrium.
  • Right Arm Injection: Microbubbles travel down the normal right SVC and opacify the Right Atrium FIRST. The coronary sinus does not opacify, or fills late via retrograde flow.
• Unroofed Coronary Sinus (Raghib Syndrome): If the left-arm injection opacifies the coronary sinus and microbubbles immediately flood directly into the left atrium (because the common wall between the CS and LA is absent), an unroofed coronary sinus defect is confirmed.

4. Postoperative Atrial Switch Baffle Leaks (Mustard / Senning)

Following atrial switch repairs for d-TGA, systemic venous blood is baffled to the subpulmonary left ventricle, and pulmonary venous blood is baffled to the subaortic right ventricle. Agitated saline injected into the upper extremity opacifies the systemic venous baffle. If microbubbles immediately cross into the pulmonary venous atrium and systemic ventricle, an active baffle leak is diagnosed, explaining systemic arterial desaturation and establishing high risk for paradoxical stroke.

---

Safety Precautions & Contraindications

Safety Screening Matrix for Agitated Saline Studies:

 ┌────────────────────────────────────────────────────────────────────────┐
 │ 1. Absolute Prevention of Macro-Air Embolism:                          │
 │    • Purge all macroscopic visible air bubbles from syringes & tubing  │
 │    • Only micro-cavitated milky emulsion is permissible                │
 ├────────────────────────────────────────────────────────────────────────┤
 │ 2. Screening for Massive Right-to-Left Shunts:                         │
 │    • Caution in severe Eisenmenger syndrome or single ventricle        │
 │    • Microbubbles entering systemic circulation directly risk          │
 │      cerebral or coronary microvascular occlusion                      │
 ├────────────────────────────────────────────────────────────────────────┤
 │ 3. Neurological Monitoring:                                            │
 │    • Immediate cessation if focal neurologic deficit, scotoma, or      │
 │      severe migraine-like headache develops                            │
 └────────────────────────────────────────────────────────────────────────┘

Preventing Macro-Air Embolism

Agitated saline relies on microscopic bubbles ($10-15\ \mu\text{m}$). Under no circumstances should visible macroscopic air bubbles be injected. Sonographers and nurses must carefully purge all visible air slugs from the stopcock, tubing, and syringe nozzles before connecting to the patient's intravenous catheter. Accidental injection of macro-air can cause mechanical vascular occlusion, acute coronary ischemia, or catastrophic cerebral air embolism.

Contraindications & Special Populations

1. Severe Pulmonary Arterial Hypertension / Eisenmenger Syndrome: In children with resting systemic-level pulmonary pressures and fixed, massive right-to-left shunting, agitated saline must be used with extreme caution. Microbubbles bypass the pulmonary filter and flood directly into the carotid arteries, where high bubble loads can cause transient cerebral ischemia.
2. Known Intracardiac Thrombus or Cerebrovascular Disease: Avoid aggressive provocative maneuvers in children with known active intracardiac thrombi, unstable stroke, or severe prothrombotic states.

---

Agitated Saline Timing Patterns & Shunt Localization Table

---

Clinical Pearls & Sonographic Traps

[!WARNING] The Delayed Transit Trap (Intracardiac vs. Intrapulmonary): A 14-year-old with biliary cirrhosis and room-air saturation of 88% undergoes an agitated saline study. The sonographer notes bubbles appearing in the left atrium and immediately reports "positive for PFO." However, careful frame-by-frame review reveals that the bubbles do not appear until cycle 5 and enter through the left upper and lower pulmonary veins! This is Hepatopulmonary Syndrome, not an intracardiac PFO. Mislabelling an intrapulmonary shunt as an intracardiac defect leads to inappropriate cardiac catheterization instead of liver transplant evaluation.

[!TIP] Diagnosing Persistent Left SVC: If the parasternal long-axis view displays an unexplained dilated, circular structure in the posterior atrioventricular groove, suspect a dilated coronary sinus secondary to a Persistent Left SVC. Do not perform the bubble study from a right arm vein! Place a peripheral IV in the left hand or left antecubital fossa. If the coronary sinus opacifies densely before a single bubble enters the right atrium, the diagnosis of PLSVC is definitively confirmed.

[!NOTE] Adding Blood to the Agitation Syringe: If agitated saline appears faint or clears within 1 to 2 beats on the ultrasound display, the bubble emulsion is unstable. Aspirate 0.5 mL of the patient's blood into the saline syringe before agitating. The blood proteins stabilize the microbubble shell, generating a dense, persistent white opacification that dramatically enhances shunt detection sensitivity.

Commercial Ultrasound Enhancing Agents (Contrast Agents)

Agitated saline and a commercial ultrasound enhancing agent (UEA) are often grouped together as "contrast echo," but they are physically opposite tools, and the ARDMS content outline lists ultrasound enhancing agents alongside strain, three-dimensional imaging, and agitated saline studies as advanced techniques a pediatric sonographer must be able to use.

Composition and the Critical Physical Difference

The agents in clinical use are Definity (perflutren lipid microsphere), Optison (perflutren protein-type A microspheres with a human albumin shell), and Lumason / SonoVue (sulfur hexafluoride lipid-type A microspheres).

This difference is the single most testable point in the topic. The agitated saline timing rule — bubbles in the left atrium within about 3 to 5 beats means an intracardiac shunt, after 5 or 6 beats means an intrapulmonary shunt — works only because normal lungs trap saline bubbles. A UEA crosses the lungs in every patient by design, so left heart opacification after a UEA injection carries no shunt information whatsoever. Using a UEA to answer a shunt question is a category error.

Pediatric Indications

Children generally have superb acoustic windows, so UEA use is far less routine than in adult laboratories. The situations where it earns its place are:

• Endocardial border definition when two or more contiguous left ventricular segments cannot be seen, most often in larger adolescents, patients with obesity, post-sternotomy patients with substernal scarring, and mechanically ventilated intensive care patients. This is what makes a reliable biplane Simpson ejection fraction possible in a difficult study.
• Mass and thrombus characterization. A UEA distinguishes an avascular apical thrombus (a filling defect that stays dark) from vascularized tumor (which enhances) and from prominent apical trabeculation in suspected left ventricular non-compaction, where contrast fills the deep intertrabecular recesses and makes the compacted-to-non-compacted ratio measurable.
• Doppler signal enhancement of a weak tricuspid or aortic regurgitant envelope, letting a right ventricular systolic pressure be estimated when the native signal is incomplete. Note that contrast exaggerates the spectral envelope edges, so the velocity must be traced along the dense modal signal rather than along the blooming outer fringe.

Note that none of these agents carries a pediatric labeled indication in most jurisdictions, so pediatric use is off-label, although it is supported by American Society of Echocardiography guidance and by a substantial pediatric safety record.

Machine Settings and Artifacts

• Drop the mechanical index to roughly 0.2 to 0.3 and select the contrast-specific imaging preset, which uses harmonic or pulse-inversion detection. A conventional imaging mechanical index destroys the microbubbles on the first sweep.
• Move the focus to the level of the mitral annulus or deeper so that the near field is not over-insonated.
• Titrate delivery. A slow continuous infusion produces steadier opacification than a bolus.

Safety

Perflutren agents carry a boxed warning for rare serious cardiopulmonary reactions, so a resuscitation-capable setting and a post-injection observation period are expected for higher-risk patients. Known hypersensitivity to perflutren, to the albumin component, or to polyethylene glycol is a contraindication. The historical absolute contraindication in patients with cardiac shunts has been removed from labeling, and current guidance permits use in patients with intracardiac shunts when clinically indicated — but caution remains warranted in severe pulmonary hypertension, and a UEA still answers none of the questions a shunt study is asked.